FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Journal of cellular and molecular medicine2018; 22(10); 4771-4793; doi: 10.1111/jcmm.13731

Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells.

Abstract: Endocrine disorders have become more and more frequently diagnosed in humans and animals. In horses, equine metabolic syndrome (EMS) is characterized by insulin resistance, hyperleptinemia, hyperinsulinemia, inflammation and usually by pathological obesity. Due to an increased inflammatory response in the adipose tissue, cytophysiological properties of adipose derived stem cells (ASC) have been impaired, which strongly limits their therapeutic potential. Excessive accumulation of reactive oxygen species, mitochondria deterioration and accelerated ageing of those cells affect their multipotency and restrict the effectiveness of the differentiation process. In the present study, we have treated ASC isolated from EMS individuals with a combination of 5-azacytydine (AZA) and resveratrol (RES) in order to reverse their aged phenotype and enhance osteogenic differentiation. Using SEM and confocal microscope, cell morphology, matrix mineralization and mitochondrial dynamics were assessed. Furthermore, we investigated the expression of osteogenic-related genes with RT-PCR. We also investigated the role of autophagy during differentiation and silenced PARKIN expression with siRNA. Obtained results indicated that AZA/RES significantly enhanced early osteogenesis of ASC derived from EMS animals. Increased matrix mineralization, RUNX-2, collagen type I and osteopontin levels were noted. Furthermore, we proved that AZA/RES exerts its beneficial effects by modulating autophagy and mitochondrial dynamics through PARKIN and RUNX-2 activity.
© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Get Full Text
Publication Date: 2018-07-12 PubMed ID: 29999247PubMed Central: PMC6156237DOI: 10.1111/jcmm.13731Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the combined effect of two substances, 5-azacytydine (AZA) and resveratrol (RES), on improving bone formation in the stem cells derived from individuals with an equine metabolic syndrome (EMS), a condition prevalent in horses that resembles human metabolic disorders.

Background

  • Equine metabolic syndrome (EMS) in horses is an endocrine disorder that mirrors similar metabolic conditions in humans, characterized by insulin resistance, elevated levels of leptin and insulin, inflammation, and often pathological obesity.
  • Adipose derived stem cells (ASC) suffer from impaired physiological properties due to increased inflammation in adipose tissue prevalent in EMS which compromises their therapeutic potential.
  • Factors such as excessive reactive oxygen species, mitochondrial degradation, and expedited aging of these cells compromise their multipotency and limit the differentiation process’s effectiveness.

Objectives

  • The study aimed to determine whether treating ASC derived from EMS individuals with a combination of 5-azacytydine (AZA) and resveratrol (RES) can reverse their aged phenotype and enhance osteogenic or bone cell differentiation.

Methods

  • Cell morphology, matrix mineralization, and mitochondrial dynamics were observed using SEM and confocal microscopes after treating ASC cells derived from EMS animals with AZA/RES.
  • Gene expression related to osteogenesis (bone formation) was studied using RT-PCR.
  • The role of autophagy (cellular self-degradation process) during differentiation was examined and PARKIN expression, which plays a role in regulating mitochondria’s activity, was silenced with siRNA.

Results

  • It was found that the combined treatment with AZA/RES significantly enhanced early osteogenesis in stem cells derived from EMS animals.
  • Increased matrix mineralization, RUNX-2, collagen type I, and osteopontin levels were noted in the treated cells suggesting successful bone formation.
  • It was also found that AZA/RES exerts its beneficial effects by modulating autophagy and mitochondrial dynamics through the activity of PARKIN and RUNX-2 genes.

Cite This Article

APA
Marycz K, Kornicka K, Irwin-Houston JM, Weiss C. (2018). Combination of resveratrol and 5-azacytydine improves osteogenesis of metabolic syndrome mesenchymal stem cells. J Cell Mol Med, 22(10), 4771-4793. https://doi.org/10.1111/jcmm.13731

Publication

Journal of cellular and molecular medicine
ISSN: 1582-4934
NlmUniqueID: 101083777
Country: England
Language: English
Volume: 22
Issue: 10
Pages: 4771-4793

Researcher Affiliations

Marycz, Krzysztof
  • Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
  • Wroclaw Research Centre EIT+, Wrocław, Poland.
Kornicka, Katarzyna
  • Department of Experimental Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
Irwin-Houston, Jennifer M
  • PferdePraxis Dr. Med. Vet. Daniel Weiss, Freienbach, Switzerland.
Weiss, Christine
  • PferdePraxis Dr. Med. Vet. Daniel Weiss, Freienbach, Switzerland.

MeSH Terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / metabolism
  • Adipose Tissue / pathology
  • Animals
  • Autophagy / drug effects
  • Autophagy / genetics
  • Azacitidine / pharmacology
  • Cell Differentiation / drug effects
  • Cellular Senescence / drug effects
  • Collagen Type I / agonists
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Core Binding Factor Alpha 1 Subunit / agonists
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Drug Combinations
  • Female
  • Gene Expression Regulation
  • Horse Diseases / drug therapy
  • Horse Diseases / genetics
  • Horse Diseases / pathology
  • Horses
  • Insulin Resistance
  • Male
  • Mesenchymal Stem Cells / drug effects
  • Mesenchymal Stem Cells / metabolism
  • Mesenchymal Stem Cells / pathology
  • Metabolic Syndrome / drug therapy
  • Metabolic Syndrome / genetics
  • Metabolic Syndrome / pathology
  • Metabolic Syndrome / veterinary
  • Mitochondrial Dynamics / drug effects
  • Obesity / drug therapy
  • Obesity / genetics
  • Obesity / pathology
  • Obesity / veterinary
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Osteogenesis / drug effects
  • Osteogenesis / genetics
  • Osteopontin / agonists
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • Oxidative Stress
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Resveratrol / pharmacology
  • Signal Transduction
  • Ubiquitin-Protein Ligases / antagonists & inhibitors
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism

References

This article includes 53 references
  1. Marycz K, Kornicka K, Szlapka-Kosarzewska J, Weiss C. Excessive Endoplasmic Reticulum Stress Correlates with Impaired Mitochondrial Dynamics, Mitophagy and Apoptosis, in Liver and Adipose Tissue, but Not in Muscles in EMS Horses.. Int J Mol Sci 2018 Jan 6;19(1).
    pmc: PMC5796114pubmed: 29316632doi: 10.3390/ijms19010165google scholar: lookup
  2. Frank N. Equine metabolic syndrome.. J Equine Vet Sci 2009;29:259‐267.
  3. Frank N, Geor GJ, Bailey SR, Durham AE, Johnson PJ. Equine metabolic syndrome.. J Vet Int Med 2010;24:467‐475.
  4. Geor RJ. Metabolic predispositions to laminitis in horses and ponies: obesity, insulin resistance and metabolic syndromes.. J Equine Vet Sci 2008;28:753‐759.
  5. Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ.. Arch Med Sci 2013 Apr 20;9(2):191-200.
    pmc: PMC3648822pubmed: 23671428doi: 10.5114/aoms.2013.33181google scholar: lookup
  6. Nishimura S, Manabe I, Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome.. Discov Med 2009 Aug;8(41):55-60.
    pubmed: 19788868
  7. Basinska K, Marycz K, Śieszek A, Nicpoń J. The production and distribution of IL-6 and TNF-a in subcutaneous adipose tissue and their correlation with serum concentrations in Welsh ponies with equine metabolic syndrome.. J Vet Sci 2015;16(1):113-20.
    pmc: PMC4367141pubmed: 25269712doi: 10.4142/jvs.2015.16.1.113google scholar: lookup
  8. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome.. Rev Endocr Metab Disord 2014 Dec;15(4):277-87.
    pubmed: 25344447doi: 10.1007/s11154-014-9301-0google scholar: lookup
  9. Lastra G, Sowers JR. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.. Horm Mol Biol Clin Investig 2013 Sep;15(2):49-57.
    pubmed: 25436732doi: 10.1515/hmbci-2013-0025google scholar: lookup
  10. Hurley DJ, Parks RJ, Reber AJ, Donovan DC, Okinaga T, Vandenplas ML, Peroni JF, Moore JN. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract.. Vet Immunol Immunopathol 2006 Apr 15;110(3-4):195-206.
    pubmed: 16290066doi: 10.1016/j.vetimm.2005.09.015google scholar: lookup
  11. de Laat MA, Kyaw-Tanner MT, Sillence MN, McGowan CM, Pollitt CC. Advanced glycation endproducts in horses with insulin-induced laminitis.. Vet Immunol Immunopathol 2012 Jan 15;145(1-2):395-401.
    pubmed: 22240145doi: 10.1016/j.vetimm.2011.12.016google scholar: lookup
  12. Manna P, Jain SK. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.. Metab Syndr Relat Disord 2015 Dec;13(10):423-44.
    pmc: PMC4808277pubmed: 26569333doi: 10.1089/met.2015.0095google scholar: lookup
  13. Marycz K, Grzesiak J, Wrzeszcz K, Golonka P. Adipose stem cell combined with plasma‐based implant bone tissue differentiation in vitro and in a horse with a phalanx digitalis distalis fracture: a case report.. Vet Med Czech Repub 2012;57:610‐617.
  14. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.. Arthritis Rheum 2009 Apr;60(4):1006-19.
    pubmed: 19333946doi: 10.1002/art.24405google scholar: lookup
  15. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication.. Leukemia 2006 Sep;20(9):1487-95.
    pubmed: 16791265doi: 10.1038/sj.leu.2404296google scholar: lookup
  16. Marędziak M, Marycz K, Lewandowski D, Siudzińska A, Śmieszek A. Static magnetic field enhances synthesis and secretion of membrane-derived microvesicles (MVs) rich in VEGF and BMP-2 in equine adipose-derived stromal cells (EqASCs)-a new approach in veterinary regenerative medicine.. In Vitro Cell Dev Biol Anim 2015 Mar;51(3):230-40.
    pmc: PMC4368852pubmed: 25428200doi: 10.1007/s11626-014-9828-0google scholar: lookup
  17. Muralidharan-Chari V, Clancy JW, Sedgwick A, D'Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression.. J Cell Sci 2010 May 15;123(Pt 10):1603-11.
    pmc: PMC2864708pubmed: 20445011doi: 10.1242/jcs.064386google scholar: lookup
  18. Pileggi A. Mesenchymal stem cells for the treatment of diabetes.. Diabetes 2012 Jun;61(6):1355-6.
    pmc: PMC3357279pubmed: 22618774doi: 10.2337/db12-0355google scholar: lookup
  19. Švajger U, Jeras M. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases.. Int Rev Immunol 2012 Jun;31(3):202-22.
    pubmed: 22587021doi: 10.3109/08830185.2012.665108google scholar: lookup
  20. Gülçin İ. Antioxidant properties of resveratrol: a structure–activity insight.. Innov Food Sci Emerg Technol 2010;11:210‐218.
  21. Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol.. Biochim Biophys Acta 2015 Jun;1852(6):1209-18.
    pubmed: 25640851doi: 10.1016/j.bbadis.2015.01.012google scholar: lookup
  22. Huang SS, Ding DF, Chen S, Dong CL, Ye XL, Yuan YG, Feng YM, You N, Xu JR, Miao H, You Q, Lu X, Lu YB. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy.. Sci Rep 2017 Apr 4;7:45692.
    pmc: PMC5379482pubmed: 28374806doi: 10.1038/srep45692google scholar: lookup
  23. Ren X, Chen L, Xie J, Zhang Z, Dong G, Liang J, Liu L, Zhou H, Luo P. Resveratrol Ameliorates Mitochondrial Elongation via Drp1/Parkin/PINK1 Signaling in Senescent-Like Cardiomyocytes.. Oxid Med Cell Longev 2017;2017:4175353.
    pmc: PMC5671746pubmed: 29201272doi: 10.1155/2017/4175353google scholar: lookup
  24. Momparler RL, Côté S, Momparler LF, Idaghdour Y. Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation.. Clin Epigenetics 2014;6(1):19.
    pmc: PMC4194463pubmed: 25313314doi: 10.1186/1868-7083-6-19google scholar: lookup
  25. Kornicka K, Marycz K, Marędziak M, Tomaszewski KA, Nicpoń J. The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells.. J Cell Mol Med 2017 Feb;21(2):387-401.
    pmc: PMC5264131pubmed: 27998022doi: 10.1111/jcmm.12972google scholar: lookup
  26. Seeliger C, Culmes M, Schyschka L, Yan X, Damm G, Wang Z, Kleeff J, Thasler WE, Hengstler J, Stöckle U, Ehnert S, Nüssler AK. Decrease of global methylation improves significantly hepatic differentiation of Ad-MSCs: possible future application for urea detoxification.. Cell Transplant 2013;22(1):119-31.
    pubmed: 22507189doi: 10.3727/096368912x638946google scholar: lookup
  27. Marycz K, Kornicka K, Grzesiak J, Śmieszek A, Szłapka J. Macroautophagy and Selective Mitophagy Ameliorate Chondrogenic Differentiation Potential in Adipose Stem Cells of Equine Metabolic Syndrome: New Findings in the Field of Progenitor Cells Differentiation.. Oxid Med Cell Longev 2016;2016:3718468.
    pmc: PMC5178365pubmed: 28053691doi: 10.1155/2016/3718468google scholar: lookup
  28. Marycz K, Kornicka K, Marędziak M, Golonka P, Nicpoń J. Equine metabolic syndrome impairs adipose stem cells osteogenic differentiation by predominance of autophagy over selective mitophagy.. J Cell Mol Med 2016 Dec;20(12):2384-2404.
    pmc: PMC5134411pubmed: 27629697doi: 10.1111/jcmm.12932google scholar: lookup
  29. Marycz K, Kornicka K, Basinska K, Czyrek A. Equine Metabolic Syndrome Affects Viability, Senescence, and Stress Factors of Equine Adipose-Derived Mesenchymal Stromal Stem Cells: New Insight into EqASCs Isolated from EMS Horses in the Context of Their Aging.. Oxid Med Cell Longev 2016;2016:4710326.
    pmc: PMC4670679pubmed: 26682006doi: 10.1155/2016/4710326google scholar: lookup
  30. Peng JY, Lin CC, Chen YJ, Kao LS, Liu YC, Chou CC, Huang YH, Chang FR, Wu YC, Tsai YS, Hsu CN. Automatic morphological subtyping reveals new roles of caspases in mitochondrial dynamics.. PLoS Comput Biol 2011 Oct;7(10):e1002212.
    pmc: PMC3188504pubmed: 21998575doi: 10.1371/journal.pcbi.1002212google scholar: lookup
  31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.. Anal Biochem 1987 Apr;162(1):156-9.
    pubmed: 2440339doi: 10.1006/abio.1987.9999google scholar: lookup
  32. Suszynska M, Poniewierska-Baran A, Gunjal P, Ratajczak J, Marycz K, Kakar SS, Kucia M, Ratajczak MZ. Expression of the erythropoietin receptor by germline-derived cells - further support for a potential developmental link between the germline and hematopoiesis.. J Ovarian Res 2014;7:66.
    doi: 10.1186/1757-2215-7-66pmc: PMC4074848pubmed: 24982693google scholar: lookup
  33. Kornicka K, Marycz K, Tomaszewski KA, Marędziak M, Śmieszek A. The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation Process.. Oxid Med Cell Longev 2015;2015:309169.
    pmc: PMC4515302pubmed: 26246868doi: 10.1155/2015/309169google scholar: lookup
  34. Kornicka K, Nawrocka D, Lis‐Bartos A. Polyurethane–polylactide‐based material doped with resveratrol decreases senescence and oxidative stress of adipose‐derived mesenchymal stromal stem cell (ASCs).. RSC Adv 2017;7:24070‐24084.
  35. Spanier G, Xu H, Xia N, Tobias S, Deng S, Wojnowski L, Forstermann U, Li H. Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).. J Physiol Pharmacol 2009 Oct;60 Suppl 4:111-6.
    pubmed: 20083859
  36. Cheng PW, Ho WY, Su YT, Lu PJ, Chen BZ, Cheng WH, Lu WH, Sun GC, Yeh TC, Hsiao M, Tseng CJ. Resveratrol decreases fructose-induced oxidative stress, mediated by NADPH oxidase via an AMPK-dependent mechanism.. Br J Pharmacol 2014 Jun;171(11):2739-50.
    pmc: PMC4243851pubmed: 24547812doi: 10.1111/bph.12648google scholar: lookup
  37. Kao CL, Tai LK, Chiou SH, Chen YJ, Lee KH, Chou SJ, Chang YL, Chang CM, Chen SJ, Ku HH, Li HY. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells.. Stem Cells Dev 2010 Feb;19(2):247-58.
    pubmed: 19656070doi: 10.1089/scd.2009.0186google scholar: lookup
  38. Shakibaei M, Shayan P, Busch F, Aldinger C, Buhrmann C, Lueders C, Mobasheri A. Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation.. PLoS One 2012;7(4):e35712.
    pmc: PMC3335081pubmed: 22539994doi: 10.1371/journal.pone.0035712google scholar: lookup
  39. Matsuzaki S, Hiratsuka T, Taniguchi M, Shingaki K, Kubo T, Kiya K, Fujiwara T, Kanazawa S, Kanematsu R, Maeda T, Takamura H, Yamada K, Miyoshi K, Hosokawa K, Tohyama M, Katayama T. Physiological ER Stress Mediates the Differentiation of Fibroblasts.. PLoS One 2015;10(4):e0123578.
    pmc: PMC4416017pubmed: 25928708doi: 10.1371/journal.pone.0123578google scholar: lookup
  40. Zhang J, Weng Y, Liu X, Wang J, Zhang W, Kim SH, Zhang H, Li R, Kong Y, Chen X, Shui W, Wang N, Zhao C, Wu N, He Y, Nan G, Chen X, Wen S, Zhang H, Deng F, Wan L, Luu HH, Haydon RC, Shi LL, He TC, Shi Q. Endoplasmic reticulum (ER) stress inducible factor cysteine-rich with EGF-like domains 2 (Creld2) is an important mediator of BMP9-regulated osteogenic differentiation of mesenchymal stem cells.. PLoS One 2013;8(9):e73086.
    pmc: PMC3760886pubmed: 24019898doi: 10.1371/journal.pone.0073086google scholar: lookup
  41. Owens SD, Kol A, Walker NJ, Borjesson DL. Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses.. Stem Cells Int 2016;2016:5830103.
    pmc: PMC5018342pubmed: 27648075doi: 10.1155/2016/5830103google scholar: lookup
  42. Liu LF, Kodama K, Wei K, Tolentino LL, Choi O, Engleman EG, Butte AJ, McLaughlin T. The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue.. Diabetologia 2015 Jul;58(7):1579-86.
    pubmed: 25952479doi: 10.1007/s00125-015-3603-ygoogle scholar: lookup
  43. Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, Martin LJ. Epigenetic regulation of motor neuron cell death through DNA methylation.. J Neurosci 2011 Nov 16;31(46):16619-36.
    pmc: PMC3238138pubmed: 22090490doi: 10.1523/jneurosci.1639-11.2011google scholar: lookup
  44. Hernandez DG, Nalls MA, Gibbs JR, Arepalli S, van der Brug M, Chong S, Moore M, Longo DL, Cookson MR, Traynor BJ, Singleton AB. Distinct DNA methylation changes highly correlated with chronological age in the human brain.. Hum Mol Genet 2011 Mar 15;20(6):1164-72.
    pmc: PMC3043665pubmed: 21216877doi: 10.1093/hmg/ddq561google scholar: lookup
  45. Carpio LR, Bradley EW, McGee-Lawrence ME, Weivoda MM, Poston DD, Dudakovic A, Xu M, Tchkonia T, Kirkland JL, van Wijnen AJ, Oursler MJ, Westendorf JJ. Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.. Sci Signal 2016 Aug 9;9(440):ra79.
    pmc: PMC5409103pubmed: 27507649doi: 10.1126/scisignal.aaf3273google scholar: lookup
  46. Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, Ng V, Xia B, Witkowski MT, Mitchell-Flack M, Grillo I, Bakogianni S, Ndiaye-Lobry D, Martín MT, Guillamot M, Banh RS, Xu M, Figueroa ME, Dickins RA, Abdel-Wahab O, Park CY, Tsirigos A, Neel BG, Aifantis I. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.. Cell 2017 Sep 7;170(6):1079-1095.e20.
    pmc: PMC5755977pubmed: 28823558doi: 10.1016/j.cell.2017.07.032google scholar: lookup
  47. Calabrese R, Valentini E, Ciccarone F, Guastafierro T, Bacalini MG, Ricigliano VA, Zampieri M, Annibali V, Mechelli R, Franceschi C, Salvetti M, Caiafa P. TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.. Biochim Biophys Acta 2014 Jul;1842(7):1130-6.
    pubmed: 24735979doi: 10.1016/j.bbadis.2014.04.010google scholar: lookup
  48. Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, Auberger P. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.. Cancer Res 2010 Feb 1;70(3):1042-52.
    pubmed: 20103647doi: 10.1158/0008-5472.can-09-3537google scholar: lookup
  49. Morselli E, Maiuri MC, Markaki M, Megalou E, Pasparaki A, Palikaras K, Criollo A, Galluzzi L, Malik SA, Vitale I, Michaud M, Madeo F, Tavernarakis N, Kroemer G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy.. Cell Death Dis 2010;1(1):e10.
    pmc: PMC3032517pubmed: 21364612doi: 10.1038/cddis.2009.8google scholar: lookup
  50. Gan KX, Wang C, Chen JH, Zhu CJ, Song GY. Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.. World J Gastroenterol 2013 Mar 14;19(10):1572-81.
    pmc: PMC3602474pubmed: 23538485doi: 10.3748/wjg.v19.i10.1572google scholar: lookup
  51. Rovira-Llopis S, Bañuls C, Diaz-Morales N, Hernandez-Mijares A, Rocha M, Victor VM. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications.. Redox Biol 2017 Apr;11:637-645.
    pmc: PMC5284490pubmed: 28131082doi: 10.1016/j.redox.2017.01.013google scholar: lookup
  52. Yang J, Wang T, Zhang Y, Li R, Wang S, Xu H, Liu J, Ye Z. Altered expression of mitofusin 2 in penile tissues of diabetic rats.. Andrologia 2014 Jun;46(5):522-8.
    pubmed: 23682852doi: 10.1111/and.12108google scholar: lookup
  53. Robb EL, Moradi F, Maddalena LA, Valente AJF, Fonseca J, Stuart JA. Resveratrol stimulates mitochondrial fusion by a mechanism requiring mitofusin-2.. Biochem Biophys Res Commun 2017 Apr 1;485(2):249-254.
    pubmed: 28235489doi: 10.1016/j.bbrc.2017.02.102google scholar: lookup

Citations

This article has been cited 21 times.
  1. Yang H, Li C, Li Y, Tai R, Sun C. Adipose-derived stem cells and obesity: The spear and shield relationship. Genes Dis 2023 Jan;10(1):175-186.
    doi: 10.1016/j.gendis.2021.09.004pubmed: 37013055google scholar: lookup
  2. Mularczyk M, Bourebaba N, Marycz K, Bourebaba L. Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis. Biomolecules 2022 Jul 27;12(8).
    doi: 10.3390/biom12081039pubmed: 36008933google scholar: lookup
  3. Wei B, Wang W, Liu X, Xu C, Wang Y, Wang Z, Xu J, Guan J, Zhou P, Mao Y. Gelatin methacrylate hydrogel scaffold carrying resveratrol-loaded solid lipid nanoparticles for enhancement of osteogenic differentiation of BMSCs and effective bone regeneration. Regen Biomater 2021 Oct;8(5):rbab044.
    doi: 10.1093/rb/rbab044pubmed: 34394955google scholar: lookup
  4. Zhao JF, Li D, An Y. [Roles of ten eleven translocation proteins family and 5-hydroxymethylcytosine in epigenetic regulation of stem cells and regenerative medicine]. Beijing Da Xue Xue Bao Yi Xue Ban 2021 Feb 22;53(2):420-424.
    doi: 10.19723/j.issn.1671-167X.2021.02.032pubmed: 33879920google scholar: lookup
  5. Park IS, Han Y, Jo H, Lee KW, Song YS. Piceatannol Is Superior to Resveratrol at Suppressing Adipogenesis in Human Visceral Adipose-Derived Stem Cells. Plants (Basel) 2021 Feb 14;10(2).
    doi: 10.3390/plants10020366pubmed: 33672932google scholar: lookup
  6. Bourebaba L, Kornicka-Garbowska K, Al Naem M, Röcken M, Łyczko J, Marycz K. MSI-1436 improves EMS adipose derived progenitor stem cells in the course of adipogenic differentiation through modulation of ER stress, apoptosis, and oxidative stress. Stem Cell Res Ther 2021 Feb 3;12(1):97.
    doi: 10.1186/s13287-020-02102-xpubmed: 33536069google scholar: lookup
  7. Ren L, Chen X, Chen X, Li J, Cheng B, Xia J. Mitochondrial Dynamics: Fission and Fusion in Fate Determination of Mesenchymal Stem Cells. Front Cell Dev Biol 2020;8:580070.
    doi: 10.3389/fcell.2020.580070pubmed: 33178694google scholar: lookup
  8. Weiss C, Kornicka-Grabowska K, Mularczyk M, Siwinska N, Marycz K. Extracellular Microvesicles (MV's) Isolated from 5-Azacytidine-and-Resveratrol-Treated Cells Improve Viability and Ameliorate Endoplasmic Reticulum Stress in Metabolic Syndrome Derived Mesenchymal Stem Cells. Stem Cell Rev Rep 2020 Dec;16(6):1343-1355.
    doi: 10.1007/s12015-020-10035-4pubmed: 32880856google scholar: lookup
  9. Golonka P, Kornicka-Garbowska K, Marycz K. SIRT1(+) Adipose Derived Mesenchymal Stromal Stem Cells (ASCs) Suspended in Alginate Hydrogel for the Treatment of Subchondral Bone Cyst in Medial Femoral Condyle in the Horse. Clinical Report. Stem Cell Rev Rep 2020 Dec;16(6):1328-1334.
    doi: 10.1007/s12015-020-10025-6pubmed: 32803696google scholar: lookup
  10. Kornicka-Garbowska K, Pędziwiatr R, Woźniak P, Kucharczyk K, Marycz K. Microvesicles isolated from 5-azacytidine-and-resveratrol-treated mesenchymal stem cells for the treatment of suspensory ligament injury in horse-a case report. Stem Cell Res Ther 2019 Dec 18;10(1):394.
    doi: 10.1186/s13287-019-1469-5pubmed: 31852535google scholar: lookup
  11. Marycz K, Szłapka-Kosarzewska J, Geburek F, Kornicka-Garbowska K. Systemic Administration of Rejuvenated Adipose-Derived Mesenchymal Stem Cells Improves Liver Metabolism in Equine Metabolic Syndrome (EMS)- New Approach in Veterinary Regenerative Medicine. Stem Cell Rev Rep 2019 Dec;15(6):842-850.
    doi: 10.1007/s12015-019-09913-3pubmed: 31620992google scholar: lookup
  12. Bourebaba L, Bedjou F, Röcken M, Marycz K. Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation. Stem Cell Res Ther 2019 Jun 18;10(1):178.
    doi: 10.1186/s13287-019-1292-zpubmed: 31215461google scholar: lookup
  13. Marycz K, Houston JMI, Weiss C, Röcken M, Kornicka K. 5-Azacytidine and Resveratrol Enhance Chondrogenic Differentiation of Metabolic Syndrome-Derived Mesenchymal Stem Cells by Modulating Autophagy. Oxid Med Cell Longev 2019;2019:1523140.
    doi: 10.1155/2019/1523140pubmed: 31214275google scholar: lookup
  14. Kornicka K, Geburek F, Röcken M, Marycz K. Stem Cells in Equine Veterinary Practice-Current Trends, Risks, and Perspectives. J Clin Med 2019 May 14;8(5).
    doi: 10.3390/jcm8050675pubmed: 31091732google scholar: lookup
  15. Cislo-Pakuluk A, Smieszek A, Kucharczyk N, Bedford PGC, Marycz K. Intra-Vitreal Administration of Microvesicles Derived from Human Adipose-Derived Multipotent Stromal Cells Improves Retinal Functionality in Dogs with Retinal Degeneration. J Clin Med 2019 Apr 13;8(4).
    doi: 10.3390/jcm8040510pubmed: 31013950google scholar: lookup
  16. Kornicka K, Śmieszek A, Szłapka-Kosarzewska J, Irwin Houston JM, Roecken M, Marycz K. Characterization of Apoptosis, Autophagy and Oxidative Stress in Pancreatic Islets Cells and Intestinal Epithelial Cells Isolated from Equine Metabolic Syndrome (EMS) Horses. Int J Mol Sci 2018 Oct 8;19(10).
    doi: 10.3390/ijms19103068pubmed: 30297648google scholar: lookup
  17. Qin Z, Zhu X, Shen Y, Ling H, Ruan N, Ye W, Xu Y, Gan X. An emerging role of mitochondrial quality control in bone metabolism: from molecular mechanisms to targeted therapeutic interventions. Cell Mol Life Sci 2025 Jul 29;82(1):291.
    doi: 10.1007/s00018-025-05802-wpubmed: 40728722google scholar: lookup
  18. Liu X, Li X. Mapping and visualization of global research progress on autophagy in metabolic dysfunction-associated steatotic liver disease and metabolic syndrome: a bibliometric analysis (2009-2024). Front Med (Lausanne) 2025;12:1525526.
    doi: 10.3389/fmed.2025.1525526pubmed: 40636387google scholar: lookup
  19. Liu Y, Wang L, Ai J, Li K. Mitochondria in Mesenchymal Stem Cells: Key to Fate Determination and Therapeutic Potential. Stem Cell Rev Rep 2024 Apr;20(3):617-636.
    doi: 10.1007/s12015-024-10681-ypubmed: 38265576google scholar: lookup
  20. Torres-Guzman RA, Avila FR, Maita K, Garcia JP, De Sario GD, Borna S, Eldaly AS, Quinones-Hinojosa A, Zubair AC, Ho OA, Forte AJ. Mesenchymal Stromal Cell Healing Outcomes in Clinical and Pre-Clinical Models to Treat Pressure Ulcers: A Systematic Review. J Clin Med 2023 Dec 7;12(24).
    doi: 10.3390/jcm12247545pubmed: 38137625google scholar: lookup
  21. Tamura N, Heidari N, Faragher RGA, Smith RKW, Dudhia J. Effects of resveratrol and its analogues on the cell cycle of equine mesenchymal stem/stromal cells. J Equine Sci 2023 Sep;34(3):67-72.
    doi: 10.1294/jes.34.67pubmed: 37781569google scholar: lookup
Subscribe to our newsletter
Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.